Other Items - Inter Pharma PCL (SET:IP)

Watchlist Manager

Watchlist

Price: 4.48 THB Market Closed

Market Cap: ฿2.7B

Inter Pharma PCL
Other Items

Quarterly

Annual

TTM

Adjust for Inflation

Cash Flow Statement

Inter Pharma PCL
Other Items Peer Comparison

Company		Other Items	CAGR 3Y	CAGR 5Y	CAGR 10Y
I	Inter Pharma PCL SET:IP	Other Items -฿51.9m	CAGR 3-Years 44%	CAGR 5-Years -38%	CAGR 10-Years N/A
D	Do Day Dream PCL SET:DDD	Other Items -฿373.8m	CAGR 3-Years N/A	CAGR 5-Years 31%	CAGR 10-Years N/A
T	Thai Nippon Rubber Industry PCL SET:TNR	Other Items ฿7.8m	CAGR 3-Years 401%	CAGR 5-Years 126%	CAGR 10-Years N/A
K	Karmarts PCL SET:KAMART	Other Items -฿437.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years -21%
A	Asian Phytoceuticals PCL SET:APCO	Other Items ฿60.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
R	Rojukis International PCL SET:KISS	Other Items -฿2.5m	CAGR 3-Years N/A	CAGR 5-Years 37%	CAGR 10-Years N/A

Inter Pharma PCL
Glance View

Market Cap

2.7B THB

Industry

Consumer products

Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.

View IP Analysis

IP Intrinsic Value

Show

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

Inter Pharma PCL
SET:IP

Inter Pharma PCL
Other Items

Inter Pharma PCL
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Inter Pharma PCL
Glance View

See Also

What is Inter Pharma PCL's Other Items?

Other Items
-51.9m THB

What is Inter Pharma PCL's Other Items growth rate?

Other Items CAGR 5Y
-38%

Company

Help

Tools

Stocks

52 Week Range	2.12 4.66
Price Target

Inter Pharma PCL SET:IP

Inter Pharma PCL Other Items

Inter Pharma PCL Other Items Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Inter Pharma PCL Glance View

See Also

What is Inter Pharma PCL's Other Items? Other Items -51.9m THB

What is Inter Pharma PCL's Other Items growth rate? Other Items CAGR 5Y -38%

Company

Help

Tools

Stocks

Inter Pharma PCL
SET:IP

Inter Pharma PCL
Other Items

Inter Pharma PCL
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Inter Pharma PCL
Glance View

What is Inter Pharma PCL's Other Items?

Other Items
-51.9m THB

What is Inter Pharma PCL's Other Items growth rate?

Other Items CAGR 5Y
-38%